Advancing Myeloma Care: Real-World Data on How CAR-T & BiTE Are Changing the Treatment Landscape

Event Description
Advancements in T-cell redirection therapies (TRT) are transforming the treatment landscape for relapsed/refractory multiple myeloma (RRMM). Dr. Natalia Neparidze will join us to discuss real-world data on CAR-T and Bispecific T-Cell Engager (BiTE) therapies, highlighting treatment patterns, safety, and clinical outcomes. Discover how these innovative therapies are shaping the future of multiple myeloma care and what they mean for patients.
Schedule & Agenda

Cynthia introduces the agenda of the event and featured speaker Dr. Natalia Neparidze

Cynthia introduces the agenda of the event and featured speaker Dr. Natalia Neparidze

Dr. Neparidze talks about CAR-T and BiTE.

Dr. Neparidze talks about CAR-T and BiTE.
Type your questions in the chat and we will answer them!
Type your questions in the chat and we will answer them!
Speakers & Moderators

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Dr. Natalia Neparidze obtained her medical degree from Aieti Medical School in Tbilisi, Georgia in 2000. She subsequently completed Postdoctoral Research Fellowships at Emory, Northwestern and Yale Universities, followed by Internal Medicine Residency and Hematology/Medical Oncology Fellowship at Yale University. She has served as an assistant professor at Yale University School of Medicine, Medical Oncology/Hematology since 2012. She specializes in multiple myeloma, monoclonal gammopathies, AL amyloidosis, & Waldenstrom's macroglobulinemia. Dr. Neparidze has developed multiple research projects in myeloma, including a number of investigator-initiated therapeutic clinical trials. She collaborates with other researchers nationally and internationally, serves as a PI and co-PI on multiple therapeutic clinical trials and leads several clinical outcomes studies in patients with myeloma.
Join the Conversation
This event is part of the Treatment & Testing group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org

Get the Latest Multiple Myeloma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Thanks to our HealthTree Community for Multiple Myeloma Sponsors:




